Diabetes and Ocular Disease

Ingrid Scott is Professor of Ophthalmology and Health Evaluation Sciences, Penn State College of Medicine Harry Flynn is Professor and The J. Donald M. Grass Distinguished Chair of Ophthalmology, Bascol Palmer Eye InstituteWES: Professor of Ophthalmology, Bascom Palmer Eye Institute

Glossary
Ingrid U. Scott, MD, MPH and Harry W. Flynn, Jr., MD

Chapter 1: Medical Overview of the Worldwide Diabetes Epidemic
Robert E. Leonard II, MD and David W. Parke II, MD

Chapter 2: Classification of Diabetic Retinopathy
Charles P. Wilkinson, MD

Chapter 3: Histopathological Manifestations of Diabetic Retinopathy
Matthew Guess, MD and Sander R. Dubovy, MD

Chapter 4: Pathogenesis of Diabetic Retinopathy
Thomas W. Gardner, MD, MS and Lloyd Paul Aiello, MD, PhD

Chapter 5: Epidemiology and Risk Factors of Diabetic Retinopathy
Tien Y. Wong, MD, PhD, Ronald Klein, MD, MPH, and Barbara E. K. Klein, MD, MPH

Chapter 6: History of Evolving Treatments for Diabetic Retinopathy
George W. Blankenship, MD

Chapter 7: Photography, Angiography, and Ultrasonography in Diabetic Retinopathy
Andrew Lam, MD, Nicholas G. Anderson, MD, Carl D. Regillo, MD, and Gary C. Brown, MD, MBA

Chapter 8: Optical Coherence Tomography in the Management of Diabetic Retinopathy
Andrew A. Moshfeghi, MD, Ingrid U. Scott, MD, MPH, Harry W. Flynn, Jr., MD, and Carmen A. Puliafito, MD, MBA

Chapter 9: Clinical Studies on Treatment for Diabetic Retinopathy
Frederick L. Ferris III, MD, Matthew D. Davis, MD, Lloyd M. Aiello, MD, and Emily Y. Chew, MD

Chapter 10: Photocoagulation for Diabetic Macular Edema and Diabetic Retinopathy
Mitchell J. Goff, MD, H. Richard McDonald, MD, and Everett Ai, MD

Chapter 11: Vitrectomy for Diabetic Retinopathy
William E. Smiddy, MD and Harry W. Flynn, Jr., MD

Chapter 12: Intravitreal Pharmacotherapies for Diabetic Retinopathy
Sophie J. Bakri, MD and Peter K. Kaiser, MD

Chapter 13: Evolving Algorithms for Managing Diabetic Macular Edema
Diana V. Do, MD and Julia A. Haller, MD

Chapter 14: Management of Diabetic Retinopathy: Evidence-based Systematic Review
Quresh Mohamed, MD, Mark C. Gillies, MD, PhD, and Tien Y. Wong, MD, PhD

Chapter 15: Cataract Management in Diabetes
Mitchell S. Fineman, MD, William E. Benson, MD, Ingrid U. Scott, MD, MPH

Chapter 16: Nonretinal Ocular Abnormalities in Diabetes
Ingrid U. Scott, MD, MPH and Harry W. Flynn, Jr., MD

Chapter 17: The Effect of Systemic Conditions on Diabetic Retinopathy
Emily Y. Chew, MD

Chapter 18: Medical Management of the Diabetic Patient
Jay S. Skyler, MD

Chapter 19: Telemedicine for Diabetic Retinopathy
Helen K. Li, MD and Matthew T. S. Tennant, MD

Chapter 20: Future Therapies: Rationale for and Status of Anti-angiogenic and Anti-permeability Interventions
Nigel H. Timothy, MD, Jennifer K. Sun, MD, Jerry Cavallerano, OD, PhD, Thomas W. Gardner, MD, MS, and Lloyd Paul Aiello, MD, PhD

Appendix: Abstracts of Major Collaborative Multicenter Trials for Diabetic Retinopathy
Compiled by Nauman A. Chaudhry, MD, Ingrid U. Scott, MD, MPH, and Harry W. Flynn, Jr., MD

Index